electroCore,

electroCore, Gross Margin

The Gross Margin of electroCore, (ECOR) as of Oct 18, 2026 is 86.75 %. In the previous year, Gross Margin was 84.97 % — a change of 2.10% (higher).

Gross Margin

86.75 %

YoY

2.10%

Last updated:

Gross Margin of electroCore, is 2025 86.75 % . Gross Margin of electroCore, was 2024 84.97 % . It decreases by 2.10% higher compared to the previous year.

For electroCore,, the gross margin of 86.8% is up versus 74.6% a few years ago.

The electroCore, Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
41.71 USD
Jan 1, 2019
51.60 USD
Jan 1, 2020
50.30 USD
Jan 1, 2021
74.59 USD
Jan 1, 2022
81.19 USD
Jan 1, 2023
82.51 USD
Jan 1, 2024
84.97 USD
Jan 1, 2025
86.75 USD
The electroCore, Gross Margin history
YEARGross MarginYoY
86.75 %+2.10%
84.97 %+2.98%
82.51 %+1.62%
81.19 %+8.85%
74.59 %+48.30%
50.30 %-2.52%
51.60 %+23.69%
41.71 %+15.56%
36.10 %-29.65%
51.31 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Frequently Asked Questions about electroCore, stock

Gross Margin of electroCore, is 86.75 % in 2025.

Gross Margin of electroCore, changed from 84.97 % to 86.75 %, representing a 2.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin electroCore, since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's electroCore, with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — electroCore,

All Key Metrics — electroCore,